Financial Results & Limited Review for March 31, 2012
Caplin Point Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended March 31, 2012.14-05-2012
14-05-2012
Appointment of Director
Caplin Point Laboratories Ltd has informed BSE that the Board of directors of the Company has, by means of a Circular Resolution passed on April 30, 2012, appointed Mr. D. P. Mishra, as a Whole Time Director of the Company with effect from May 01, 2012 for a period of 2 years. The appointment is subject to the approval of the Shareholders at the ensuing general meeting. Mr. D. P. Mishra has rich and varied experience in operational areas, with special...02-05-2012
Change in Directorate
Caplin Point Laboratories Ltd has informed BSE that Mr. Lakshman Balasubramanian, the Vice President - Corporate Affairs of the Company has resigned from his position on March 05, 2012 and the same has been accepted by the Management with effect from close of working hours on the said date.07-03-2012
Financial Results & Limited Review for Dec 31, 2011
Caplin Point Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2011.14-02-2012
Updates on Outcome of AGM
Caplin Point Laboratories Ltd has informed BSE that the members at the 20th Annual General Meeting (AGM) of the Company held on December 29, 2011, inter alia, have accorded to the following:1. Adoption of the Audited Balance Sheet as at June 30, 2011 and the Profit and Loss Account for the Financial Year ended June 30, 2011, and the Directors Report and the Auditors Report thereon....05-01-2012
Outcome of AGM
Caplin Point Laboratories Ltd has informed BSE that the members of the Company at the 20th Annual General Meeting held on December 29, 2011 have approved the re-appointment of Mr. M. Jayapal as Managing Director of the Company for a period of 2 years with effect from March 28, 2011.02-01-2012
Appointment of Head - Formulation & Development
Caplin Point Laboratories Ltd has informed BSE that Mr. Mr. V Natarajan, a research and development professional having rich and varied experience has been appointed to the position of Head - Formulation & Development -Injectibles of the Company and he shall be in overall charge of the Formulation & Development function of the Company.02-01-2012
Outcome of Board Meeting
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 21, 2011, has decided to reconstitute the AUDIT COMMITTEE of the Board by inducting Mr. N. R. Achan, Director into the said committee and by appointing him as the Chairman of the Audit Committee with immediate effect. Mr. N. R. Achan is the former Chairman and CEO of Catholic Syrian Bank Ltd. and is a veteran Banker with considerable...28-11-2011
Fixes Book Closure for Final Dividend & AGM
Caplin Point Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 24, 2011 to December 29, 2011 (both days inclusive) for the purpose of Payment of Final Dividend & 20th Annual General Meeting (AGM) of the Company to be held on December 29, 2011.22-11-2011
Audited Financial Results for June 30, 2011
Caplin Point Laboratories Ltd has informed BSE about the Audited Financial Results for the period ended June 30, 2011.21-11-2011